Defective monocyte dynamics in Q fever granuloma deficiency

The Journal of Infectious Diseases
Amélie DelabyJean-Louis Mege

Abstract

The outcome of Q fever, an infectious disease caused by Coxiella burnetii, is associated with granuloma formation. Granulomas are present in patients with resolutive Q fever but are lacking in patients with chronic Q fever. Study of granuloma formation requires invasive approaches. Here, we took advantage of a recently described method that enables in vitro generation of human granulomas specific for C. burnetii. Circulating mononuclear cells progressively accumulated around beads coated with C. burnetii extracts, and complete granulomas were generated in 8 days. Granuloma cells consisted of macrophages, lymphocytes, and, to a lesser extent, epithelioid cells and multinucleated giant cells. Early events that govern granuloma formation were studied using live-imaging microscopy. Monocytes migrated toward C. burnetii-coated beads independently of the presence of T lymphocytes and then recruited T lymphocytes. About 90% of patients with chronic Q fever failed to form granulomas. This deficiency was associated with defective migration of monocytes toward coated beads. Monocytes were involved in the early stages of granuloma formation and recruited T lymphocytes to complete granuloma formation. This article describes a direct relati...Continue Reading

References

Jun 1, 1987·Journal of Clinical Gastroenterology·P WestlakeJ K Kelly
Jan 1, 1980·Human Pathology·M PellegrinJ J Voigt
Mar 1, 1994·Clinical and Diagnostic Laboratory Immunology·H T DupontD Raoult
Oct 9, 1999·Clinical Microbiology Reviews·M Maurin, D Raoult
May 19, 2000·Infection and Immunity·J DellacasagrandeJ L Mege
Mar 22, 2002·Nature Reviews. Immunology·R Medzhitov
Jan 15, 2004·The Journal of Infectious Diseases·Marc LeoneJean-Louis Mege
Mar 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Amélie HonstettreJean-Louis Mege
Mar 29, 2005·The Lancet Infectious Diseases·D RaoultJl Mege
Dec 20, 2005·The Journal of Pathology·Timo Ulrichs, Stefan H E Kaufmann
Jul 11, 2006·The Journal of Infectious Diseases·Soraya MeghariJean-Louis Mege
Jan 11, 2007·Immunology and Cell Biology·Bernadette M Saunders, Warwick J Britton
Nov 6, 2007·Frontiers in Bioscience : a Journal and Virtual Library·Fernando Oneissi MartinezMassimo Locati
Nov 8, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M LukácováJ Kazár
Dec 19, 2007·Immunobiology·Laura Helming, Siamon Gordon
Mar 20, 2008·European Journal of Immunology·Marie BenoitJean-Louis Mege
Aug 21, 2009·Nature Immunology·David G RussellFrédéric Altare
Jun 22, 2010·Journal of Immunological Methods·Amélie DelabyJean-Louis Mège
Aug 20, 2010·Journal of Leukocyte Biology·Abdoulaye Oury BarryEric Ghigo

❮ Previous
Next ❯

Citations

Nov 5, 2014·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S A AsnerG Greub
Sep 13, 2012·Journal of Proteomics·Richard OuedraogoJulien Textoris
Jan 8, 2015·Frontiers in Cellular and Infection Microbiology·Delphine FaugaretJean-Louis Mège
Jul 22, 2016·PloS One·Julie AlingrinJean-Louis Mege
Nov 20, 2016·Clinical Microbiology Reviews·Carole EldinDidier Raoult
Jun 14, 2016·The Pediatric Infectious Disease Journal·Joshua R FrancisClare Nourse
May 16, 2020·Frontiers in Cellular and Infection Microbiology·Aurélie DaumasJean-Louis Mege
Aug 8, 2021·Diagnostics·Thomas El JammalPascal Sève

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.